These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 12207332

  • 1. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T, Gerlach J, Muller K, Marinkovic D, Hess J, Nitschke L, Wirth T.
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [Abstract] [Full Text] [Related]

  • 2. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
    Hess J, Nielsen PJ, Fischer KD, Bujard H, Wirth T.
    Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
    [Abstract] [Full Text] [Related]

  • 3. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J, Ghosh S, Jumaa H, Reth M, Wienands J, Chan AC, Nitschke L.
    Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
    [Abstract] [Full Text] [Related]

  • 4. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation.
    Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P.
    Nature; 1996 Oct 10; 383(6600):538-42. PubMed ID: 8849727
    [Abstract] [Full Text] [Related]

  • 5. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.
    Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M, Roeder RG.
    Nature; 1996 Oct 10; 383(6600):542-7. PubMed ID: 8849728
    [Abstract] [Full Text] [Related]

  • 6. B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice.
    Brunner C, Marinkovic D, Klein J, Samardzic T, Nitschke L, Wirth T.
    J Exp Med; 2003 May 05; 197(9):1205-11. PubMed ID: 12732662
    [Abstract] [Full Text] [Related]

  • 7. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA.
    Nature; 2003 May 05; 384(6610):634-7. PubMed ID: 8967951
    [Abstract] [Full Text] [Related]

  • 8. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
    Laumen H, Nielsen PJ, Wirth T.
    Eur J Immunol; 2000 Feb 05; 30(2):458-69. PubMed ID: 10671201
    [Abstract] [Full Text] [Related]

  • 9. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C, Wirth T.
    Nucleic Acids Res; 2006 Feb 05; 34(6):1807-15. PubMed ID: 16582106
    [Abstract] [Full Text] [Related]

  • 10. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
    Sato S, Tuscano JM, Inaoki M, Tedder TF.
    Semin Immunol; 1998 Aug 05; 10(4):287-97. PubMed ID: 9695185
    [Abstract] [Full Text] [Related]

  • 11. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.
    Arthritis Rheum; 2003 Jun 05; 48(6):1612-21. PubMed ID: 12794829
    [Abstract] [Full Text] [Related]

  • 12. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ, McLean PA, Neel BG, Wortis HH.
    J Immunol; 1997 Nov 01; 159(9):4233-43. PubMed ID: 9379018
    [Abstract] [Full Text] [Related]

  • 13. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
    Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF.
    Nat Immunol; 2004 Oct 01; 5(10):1078-87. PubMed ID: 15378059
    [Abstract] [Full Text] [Related]

  • 14. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.
    Nielsen PJ, Georgiev O, Lorenz B, Schaffner W.
    Eur J Immunol; 1996 Dec 01; 26(12):3214-8. PubMed ID: 8977324
    [Abstract] [Full Text] [Related]

  • 15. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.
    Brunner C, Sindrilaru A, Girkontaite I, Fischer KD, Sunderkötter C, Wirth T.
    EMBO J; 2007 Jul 11; 26(13):3191-202. PubMed ID: 17568779
    [Abstract] [Full Text] [Related]

  • 16. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1.
    Schubart K, Massa S, Schubart D, Corcoran LM, Rolink AG, Matthias P.
    Nat Immunol; 2001 Jan 11; 2(1):69-74. PubMed ID: 11135581
    [Abstract] [Full Text] [Related]

  • 17. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L, Carsetti R, Ocker B, Köhler G, Lamers MC.
    Curr Biol; 1997 Feb 01; 7(2):133-43. PubMed ID: 9016707
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
    Viemann D, Schlenke P, Hammers HJ, Kirchner H, Kruse A.
    Eur J Immunol; 2000 Feb 01; 30(2):550-9. PubMed ID: 10671211
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.
    Qin XF, Reichlin A, Luo Y, Roeder RG, Nussenzweig MC.
    EMBO J; 1998 Sep 01; 17(17):5066-75. PubMed ID: 9724642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.